Literature DB >> 6498081

Cross-resistance to cytotoxic drugs in human glioma cell lines in culture.

S Merry, S B Kaye, R I Freshney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498081      PMCID: PMC1976996          DOI: 10.1038/bjc.1984.263

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  17 in total

1.  Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response.

Authors:  D Kessel; V Botterill; I Wodinsky
Journal:  Cancer Res       Date:  1968-05       Impact factor: 12.701

2.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.

Authors:  J L Biedler; H Riehm
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

3.  Drug sensitivity of an adriamycin-resistant mutant subline of mouse lymphoblastoma L5178Y cells.

Authors:  T Nishimura; K Muto; N Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1978-05       Impact factor: 2.649

Review 4.  The clinical pharmacology of VM26 and VP16-213. A brief overview.

Authors:  P J Creaven
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.

Authors:  R K Johnson; M P Chitnis; W M Embrey; E B Gregory
Journal:  Cancer Treat Rep       Date:  1978-10

6.  Cross resistance between actinomycin-D, adriamycin and vincristine in a murine solid tumour in vivo.

Authors:  S B Kaye; J A Boden
Journal:  Biochem Pharmacol       Date:  1980-04-01       Impact factor: 5.858

7.  Induced resistance in leukaemia L1210 to adriamycin and its cross-resistance to vincristine and bouvardin.

Authors:  M P Chitnis; S S Joshi; R P Gude; R S Menon
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

8.  Pharmacokinetics of vincristine sulfate in adult cancer patients.

Authors:  V S Sethi; D V Jackson; D R White; F Richards; J J Stuart; H B Muss; M R Cooper; C L Spurr
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

9.  Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells.

Authors:  F Baskin; R N Rosenberg; V Dev
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

10.  Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment.

Authors:  R I Freshney; J Paul; I M Kane
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

View more
  7 in total

1.  Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.

Authors:  S P Cole
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.

Authors:  G Nikkhah; J C Tonn; O Hoffmann; H P Kraemer; J L Darling; R Schönmayr; W Schachenmayr
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

3.  Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.

Authors:  S Merry; P Flanigan; E Schlick; R I Freshney; S B Kaye
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

4.  Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamil.

Authors:  S Merry; E R Courtney; C A Fetherston; S B Kaye; R I Freshney
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

5.  Resistance of human glioma to adriamycin in vitro: the role of membrane transport and its circumvention with verapamil.

Authors:  S Merry; C A Fetherston; S B Kaye; R I Freshney; J A Plumb
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

6.  Occurrence of a multidrug-resistant phenotype in human lung xenografts.

Authors:  J Mattern; M Bak; M Volm
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

7.  Enhanced effect of reserpine upon growth-inhibitory action of ACNU on ACNU-resistant C6 glioma.

Authors:  T Yoshida; K Shimizu; Y Ushio; T Hayakawa; H Mogami; Y Sakamoto
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.